neostigmine has been researched along with Constriction, Pathological in 3 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we tested the effects of a cholinesterase inhibitor, neostigmine, and a muscarinic cholinergic agonist, pilocarpine, on cardiac hypertrophy and TNF alpha levels during pressure overload." | 7.74 | Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. ( Freeling, J; LaCroix, C; Li, YF; Wattier, K, 2008) |
| " In the present study, we tested the effects of a cholinesterase inhibitor, neostigmine, and a muscarinic cholinergic agonist, pilocarpine, on cardiac hypertrophy and TNF alpha levels during pressure overload." | 3.74 | Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload. ( Freeling, J; LaCroix, C; Li, YF; Wattier, K, 2008) |
| "Ampullary stenosis was confirmed in all patients who subsequently underwent sphincteroplasty." | 1.26 | Duodenoscopy and endoscopic pancreatography in patients with postive morphine prostigmine tests. ( Capobianco, AG; Frager, SH; Gregg, JA; McCartney, AJ; Milano, AF; Santoro, BT; Taddeo, AE, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STRAFFON OSORNO, AE | 1 |
| TREVINO, H | 1 |
| Freeling, J | 1 |
| Wattier, K | 1 |
| LaCroix, C | 1 |
| Li, YF | 1 |
| Gregg, JA | 1 |
| Taddeo, AE | 1 |
| Milano, AF | 1 |
| McCartney, AJ | 1 |
| Santoro, BT | 1 |
| Frager, SH | 1 |
| Capobianco, AG | 1 |
3 other studies available for neostigmine and Constriction, Pathological
| Article | Year |
|---|---|
[Diagnostic value of neostigmine in congenital hypertrophy of the pylorus].
Topics: Constriction, Pathologic; Hypertrophy; Neostigmine; Pylorus | 1955 |
Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload.
Topics: Animals; Animals, Newborn; Body Weight; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Dru | 2008 |
Duodenoscopy and endoscopic pancreatography in patients with postive morphine prostigmine tests.
Topics: Adolescent; Adult; Biliary Tract Diseases; Cholangiography; Cholecystectomy; Chronic Disease; Cicatr | 1977 |